Innovita Biological Technology Co., Ltd. (SHA:688253)
58.59
+0.29 (0.50%)
At close: Jul 15, 2026
Innovita Biological Technology Company Description
Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products.
It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing.
The company was founded in 2006 and is based in Beijing, China.
Innovita Biological Technology Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 571 |
| CEO | Xiujie Zhang |
Contact Details
Address: 1st and 2nd floors Beijing, 100070 China | |
| Phone | 86 10 8368 1277 |
| Website | innovita.com.cn |
Stock Details
| Ticker Symbol | 688253 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005Q14 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Xiujie Zhang | GM and Director |
| Xiujuan Zhao | Financial Director and Director |
| Xiaogang Zhang | Deputy GM and Director |
| Fukang Chen | Board Secretary |
| Ying Zhao | Accounting Supervisor |